Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 23Lymphoma, Mantle-Cell 14Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 5Waldenstrom Macroglobulinemia 4Lymphoma, B-Cell 4Lymphoma 4Leukemia, B-Cell 4Leukemia 3Neoplasms 2Melanoma 2Leukemia, Prolymphocytic 2Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurologic Manifestations 1Myeloproliferative Disorders 1Lymphoma, AIDS-Related 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Lymphoid 1Leukemia, Hairy Cell 1Hematologic Diseases 1Graft vs Host Disease 1Glioblastoma 1Disease Progression 1Central Nervous System Neoplasms 1Cardiovascular Diseases 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

Social Determinants of Health 2Exercise 2sofosbuvir-velpatasvir drug combination 1ribociclib 1palbociclib 1ibrutinib 1amlodipine, atorvastatin drug combination 1acalabrutinib 1abemaciclib 1Standard of Care 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Methods 1Interviews as Topic 1Hematologic Tests 1Fish Oils 1Fatty Acids, Omega-3 1Electrocardiography 1Educational Status 1Echocardiography 1Early Intervention, Educational 1Diet 1Cholecalciferol 1Chemoradiotherapy 1Atorvastatin 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Cardiovascular Diseases × ibrutinib × Clear all
NCT06561243 2024-08-21

Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies

University Hospital, Caen

Active not recruiting
15,000 enrolled

Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡